Related content

Weekly docetaxel and concomitant boost radiotherapy for non-small cell lung cancer. A phase I/II dose escalation trial

By Koukourakis M.I.   Kourousis C.   Kamilaki M.   Koukouraki S.   Giatromanolaki A.   Kakolyris S.   Kotsakis A.   Androulakis N.   Bahlitzanakis N.   Georgoulias V.  

European Journal of Cancer, Vol. 34, Iss. 6, 1998-05 ,pp. : 838-844

Elsevier

Access to resources Recommend Favorite

Radiotherapy with concomitant weekly docetaxel for Stages III/IV oropharynx carcinoma. Results of the 98-02 GORTEC Phase II trial

By Calais G.   Bardet E.   Sire C.   Alfonsi M.   Bourhis J.   Rhein B.   Tortochaux J.   Man Y.T.K.   Auvray H.   Garaud P.  

International Journal of Radiation Oncology*Biology*Physics, Vol. 58, Iss. 1, 2004-01 ,pp. : 161-166

Elsevier

Access to resources Recommend Favorite

Phase I/II study of docetaxel, cisplatin and S1 in locally advanced, recurrent and metastatic head and neck squamous cell carcinoma

By                      

Oncology Letters, Vol. 4, Iss. 5, 2012-01 ,pp. : 898-904

Spandidos Publications

Access to resources Recommend Favorite

Phase I trial of combined chemotherapy with docetaxel, cisplatin, and 5-fluorouracil for patients with locally advanced squamous cell carcinoma of the head and neck

By Tsukuda Mamoru   Mikami Yasukazu   Tanigaki Yuji   Katori Hideaki   Horiuchi Choichi   Ikeda Yoichi   Taguchi Takahide   Ono Machiko   Yoshida Takahumi   Sakuma Yasunori   Aikoh Ken  

International Journal of Clinical Oncology, Vol. 9, Iss. 3, 2004-06 ,pp. : 161-166

Springer Publishing Company

Access to resources Recommend Favorite

Mature Results of a Phase II Trial of Concomitant Cisplatin/Pelvic Radiotherapy for Locally Advanced Squamous Cell Carcinoma of the Cervix

By Fields A.L.   Anderson P.S.   Goldberg G.L.   Wadler S.   Beitler J.   Sood B.   Runowicz C.D.  

Gynecologic Oncology, Vol. 61, Iss. 3, 1996-06 ,pp. : 416-422

Academic Press

Access to resources Recommend Favorite